170 related articles for article (PubMed ID: 31225807)
1. Selective deep brain stimulation in the substantia nigra reduces myoclonus in progressive myoclonic epilepsy: a novel observation and short review of the literature.
di Giacopo A; Baumann CR; Kurthen M; Capecchi F; Sürücü O; Imbach LL
Epileptic Disord; 2019 Jun; 21(3):283-288. PubMed ID: 31225807
[TBL] [Abstract][Full Text] [Related]
2. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
[TBL] [Abstract][Full Text] [Related]
3. Deep brain stimulation in a patient with progressive myoclonic epilepsy and ataxia due to potassium channel mutation (MEAK). A case report and review of the literature.
Sobstyl M; Kożuch N; Iwaniuk-Gugała M; Stapińska-Syniec A; Konopko M; Jezierski P
Epilepsy Behav Rep; 2023; 24():100627. PubMed ID: 37928363
[TBL] [Abstract][Full Text] [Related]
4. Chronic high-frequency deep brain stimulation of the STN/SNr for progressive myoclonic epilepsy.
Vesper J; Steinhoff B; Rona S; Wille C; Bilic S; Nikkhah G; Ostertag C
Epilepsia; 2007 Oct; 48(10):1984-9. PubMed ID: 17561948
[TBL] [Abstract][Full Text] [Related]
5. Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients.
Alavi M; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
Exp Neurol; 2013 Jul; 245():60-71. PubMed ID: 23063495
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological validation of STN-SNr boundary depicted by susceptibility-weighted MRI.
McEvoy J; Ughratdar I; Schwarz S; Basu S
Acta Neurochir (Wien); 2015 Dec; 157(12):2129-34. PubMed ID: 26489736
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.
Galati S; Mazzone P; Fedele E; Pisani A; Peppe A; Pierantozzi M; Brusa L; Tropepi D; Moschella V; Raiteri M; Stanzione P; Bernardi G; Stefani A
Eur J Neurosci; 2006 Jun; 23(11):2923-8. PubMed ID: 16819981
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Attentional Performance in Parkinson's Disease: The Impact of Combined Deep Brain Stimulation of the Substantia Nigra Pars Reticulata and the Subthalamic Nucleus.
Thein J; Linnhoff S; Voges J; Galazky I; Zaehle T
Am J Med; 2024 Jul; 137(7):673-676. PubMed ID: 38499137
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation attenuates motor seizures via modulating the nigral orexin pathway.
Xue T; Wang S; Chen S; Wang H; Liu C; Shi L; Bai Y; Zhang C; Han C; Zhang J
Front Neurosci; 2023; 17():1157060. PubMed ID: 37214393
[TBL] [Abstract][Full Text] [Related]
10. Suppression of secondary generalization of limbic seizures by stimulation of subthalamic nucleus in rats.
Usui N; Maesawa S; Kajita Y; Endo O; Takebayashi S; Yoshida J
J Neurosurg; 2005 Jun; 102(6):1122-9. PubMed ID: 16028773
[TBL] [Abstract][Full Text] [Related]
11. Persistent synaptic inhibition of the subthalamic nucleus by high frequency stimulation.
Steiner LA; Kühn AA; Geiger JR; Alle H; Popovic MR; Kalia SK; Hodaie M; Lozano AM; Hutchison WD; Milosevic L
Brain Stimul; 2022; 15(5):1223-1232. PubMed ID: 36058524
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood.
Yan H; Toyota E; Anderson M; Abel TJ; Donner E; Kalia SK; Drake J; Rutka JT; Ibrahim GM
J Neurosurg Pediatr; 2018 Nov; 23(3):274-284. PubMed ID: 30544364
[TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat.
Sutton AC; Yu W; Calos ME; Smith AB; Ramirez-Zamora A; Molho ES; Pilitsis JG; Brotchie JM; Shin DS
J Neurophysiol; 2013 Jan; 109(2):363-74. PubMed ID: 23076106
[TBL] [Abstract][Full Text] [Related]
14. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
[TBL] [Abstract][Full Text] [Related]
16. Progressive brain metabolic changes under deep brain stimulation of subthalamic nucleus in parkinsonian rats.
Melon C; Chassain C; Bielicki G; Renou JP; Kerkerian-Le Goff L; Salin P; Durif F
J Neurochem; 2015 Mar; 132(6):703-12. PubMed ID: 25533782
[TBL] [Abstract][Full Text] [Related]
17. Microstimulation-induced inhibition as a tool to aid targeting the ventral border of the subthalamic nucleus.
Lafreniere-Roula M; Hutchison WD; Lozano AM; Hodaie M; Dostrovsky JO
J Neurosurg; 2009 Oct; 111(4):724-8. PubMed ID: 19408978
[TBL] [Abstract][Full Text] [Related]
18. Stop! border ahead: Automatic detection of subthalamic exit during deep brain stimulation surgery.
Valsky D; Marmor-Levin O; Deffains M; Eitan R; Blackwell KT; Bergman H; Israel Z
Mov Disord; 2017 Jan; 32(1):70-79. PubMed ID: 27709666
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic stimulation-induced forelimb dyskinesias are linked to an increase in glutamate levels in the substantia nigra pars reticulata.
Boulet S; Lacombe E; Carcenac C; Feuerstein C; Sgambato-Faure V; Poupard A; Savasta M
J Neurosci; 2006 Oct; 26(42):10768-76. PubMed ID: 17050715
[TBL] [Abstract][Full Text] [Related]
20. Frequency-dependent, transient effects of subthalamic nucleus deep brain stimulation on methamphetamine-induced circling and neuronal activity in the hemiparkinsonian rat.
So RQ; McConnell GC; Grill WM
Behav Brain Res; 2017 Mar; 320():119-127. PubMed ID: 27939691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
